Glucagon-like peptide-1 receptor agonists, specifically semaglutide and liraglutide, designed for type 2 diabetes mellitus treatment, have been explored as drugs for the treatment of obesity
Being overweight or obese leads to a build-up of visceral fat a type of fat that wraps around the organs and increases the risk of conditions such as heart disease and diabetes which triggers inflammation, creating an environment for cells to multiply uncontrollably
What should I eat to avoid plateauing on GLP-1s
Reduced Physical Activity Reduced caloric intake on GLP-1 medications sometimes comes alongside reduced physical activity, either because fatigue is a factor in the early weeks or because lower energy availability makes exercise feel harder
YangYLinYWangMYuanKWangQMuPet al
Efficacy: Both Ozempic and other GLP-1 medications have been shown to help with weight loss, but some studies suggest that newer GLP-1 drugs may have slightly greater effects on weight reduction